Difference between revisions of "Supporting Key Legislative and Policy Changes"

From Media Wiki
Jump to: navigation, search
 
(71 intermediate revisions by 3 users not shown)
Line 1: Line 1:
<div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="wiki" id="content_view" style="display: block">
 
Return to [[Opioid_Top-Level_Strategy_Map|Opioid Top-Level Strategy Map&nbsp;]]<span style="font-size: 13px;">or the </span>[[ZOOM_MAP_-_Expand_Harm_Reduction_Practices_Associated_with_Opioid_Misuse|Zoom Map - Expand Harm Reduction Practices Associated with Opioid Misuse]]
 
  
= State Policy Guide =
+
&nbsp;
 +
 
 +
= Introductory Paragraph =
 +
 
 +
Educating policymakers and the general public about the legislative or policy changes necessary to create change in your community is an important step to addressing substance misuse and substance use disorder (SUD). Policies help states and local communities in several important ways:
  
The National Center on Addiction and Substance Abuse produced a[https://www.centeronaddiction.org/addiction-research/reports/ending-opioid-crisis-practical-guide-state-policymakers Practical Guide for State Policymakers] that was released in October of 2017
+
1. By providing direct funding to communities for treatment and other services.<br/> 2. By improving access and/or affordability of care to individuals in need of assistance.<br/> 3. By removing barriers that prevent or limit the use of best practices across government agencies.
  
&nbsp; Addiction Policy Forum released a report on [https://www.addictionpolicy.org/blog/addiction-policy-forum-releases-report-on-policy-responses-to-addiction Policy Responses to Addiction]
+
Policy change can take place at all levels of government.&nbsp; This page will provide information about how policy changes typically take place, as well as some examples of federal, state, and local laws that have helped local communities.&nbsp;&nbsp;
  
 
&nbsp;
 
&nbsp;
  
= General Information =
+
= Key Information =
  
A policy can allow doctors to hold patients who show signs of opioid misuse. This was proposed, but not passed in Massachusetts<sup class="reference">[1]</sup>
+
'''Initial Steps for Policy Advocacy'''<br/> In order to bring about policy changes through laws or ordinances, any group of citizens must be able to become a "constituency of consequence" to those with the ability to create and change policy.&nbsp; This can be accomplished with a number of different advocacy approaches, as highlighted below.&nbsp; A few key principles to change policy at any level of government include:
  
&nbsp; In June 2016, the American Medical Association (AMA) held its annual conference and discussed ways in which healthcare professionals could address the opioid epidemic. The AMA's new president, Dr. Andrew Gurman, acknowledged that physicians have played a key role in creating the opioid epidemic. The AMA House of Delegates called for measures that would oppose barriers that can limit patient access to evidence-based, non-opioid and non-pharmaceutical therapies. In addition, they also called for having pain removed as a vital sign in professional standards, and to disconnect patient satisfaction scores from questions related to evaluation and management of pain in order to minimize prescribing opioids. The AMA also discussed increasing access to Naloxone, a drug that can counter the effect of an opioid overdose. In order to increase access to Naloxone, they called for public and private payers to include the drug on their preferred drug lists and formularies with little to no cost-sharing, liability protections for healthcare professionals who administer, prescribe, or dispense the drug, and to make the drug available at all pharmacies, at community-based organizations, correctional settings, schools, and law enforcement agencies.<sup class="reference">[2]</sup>
+
*Have clear policy objectives.&nbsp; The more specific and narrow the objective the better.&nbsp; If the policy goals are too broad or general, it is easy for legislators to object on that basis.
 +
*Support your position.&nbsp; Have research and data to support why the policy change you are seeking would be beneficial.&nbsp; For example, if seeking to improve harm reduction through the creation of a needle exchange program, provide data on expected lives that will be saved, reduced medical costs, improved linkages to care, and other benefits.  
 +
*Build a coalition.&nbsp; It is important to build a coalition to increase political clout.&nbsp; Think about other groups within the state or local community whose goals align with yours that would support your policy objectives and who would be willing to take action in order to achieve it.&nbsp; For example, if you were advocating for a needle exchange program, you might seek support from harm reduction organizations including hospitals, community health organizations and professionals, the recovery community, families in support of recovery, the treatment community, and potentially many others.&nbsp;&nbsp;
 +
*Know your opposition.&nbsp; If a policy change hasn't happened, it is likely opposition exists.&nbsp; It is important to learn why policymakers may be hesitant to make a certain change, including what groups oppose the policy and why.&nbsp; Learning about the other side is critical to developing an effective advocacy strategy.&nbsp; Overcoming opposition may require education, effective counterarguments, financial resources, and increased public awareness.
 +
*Identify champions.&nbsp; The most successful efforts resulting in desired policy changes are led by individuals who are passionate about the issue.&nbsp; Identifying and working with champions in the state or local government is a big key to success.&nbsp; It is important to have people "on the inside" that can hold hearings, develop legislation, utilize input and information from stakeholders, and provide insight on the process.&nbsp; Leaders within the coalition of groups seeking the policy change are also critical to identify.
 +
*Your voice matters.&nbsp; Many times, individuals or groups with minimal advocacy experience can be intimidated by the process.&nbsp; Remember that those "in power" are there because they were elected to serve.&nbsp; Lawmakers across all levels of government represent the people of their states, districts, cities, towns, and so forth.&nbsp; It is your constitutional right to petition the government and be heard.&nbsp; Those representing the people need to hear the concerns of all those they represent.  
  
&nbsp; There are contrasting reports on the effectiveness of policies on opioid prescribing and opioid and heroin overdose rates. In June 2016, UC Irvine Health reported that between 2006 and 2012, states enacted 81 laws to control use of powerful opioids such as Oxycontin and Vicodin. But even with these new prescription-drug monitoring programs and other regulations, researchers at Dartmouth Institute for Health Policy and Clinical Practice found that 45% of disabled Medicare beneficiaries were still using opioids in 2012. The same study found no discernible difference in opioid use or overdose as a result of tighter regulations. <sup class="reference">[3]</sup> In contrast, a study published in the October 2016 issue of Health Affairs reported that combined implementation of mandated provider review of state-run prescription drug monitoring program data and pain clinic laws reduced opioid amounts prescribed by 8 percent and prescription opioid overdose death rates by 12 percent form 2006-2013.<sup class="reference">[4]</sup>
+
'''Converting Policy Into Action'''<br/> After taking the initial steps to organize, conduct both supportive and opposition research, identify champions, and reach consensus on what the policy objective(s) should be, the next step is identify and implement a set of strategies that will grow public and political support for those policies.&nbsp; While approaches and specific strategies and almost innumerable, taking action involves communication and messaging intended to educate and influence.&nbsp;&nbsp;
  
&nbsp; In their 2015 report, the National Heroin Task Force stated that policies regarding opioid and heroin use must be grounded in scientific understanding that substance use disorders are a chronic brain disease that can be prevented and treated, leading to recovery.<sup class="reference">[5]</sup>
+
'''Grassroots Advocacy'''<br/> Grassroots Advocacy generally refers to engaging the public to actively educate and lobby on behalf of a desired policy objective.&nbsp; Communication occurs through letters, emails, calls to legislators, rallies, social media campaigns, letters to the editor, and other forms of messaging campaigns designed to put political pressure on policymakers to enact desired changes.&nbsp; A good overview of grassroots advocacy can be found here.
  
&nbsp;
+
'''Direct Lobbying'''<br/> Direct lobbying refers to direct communication and meetings with policy makers, most often governors, mayors, county executives, and the legislative branch at all levels of government. This key activity provides the opportunity to meet with decision makers and their staff to discuss the desired policy goals, the benefits and support, address any likely opposition, and gauge the receptiveness of the policymakers.<br/> Opportunities for direct lobbying often take place during the legislative session, which varies from jurisdiction to jurisdiction.&nbsp; Some advocates and interest groups will organize a "lobby day" where members converge in Washington, state capitols, or with local legislative bodies to advocate for desired policy objectives.&nbsp; When the legislative body is not in session, advocates can meet with their representatives at their local offices.&nbsp; A good resource on the process of influencing policy can be found here.
  
= Promising Legislation =
+
'''Lobbying Rules and Restrictions'''<br/> Lobbying rules vary widely between levels of government and across all states.&nbsp; It is, therefore, important to know how lobbying is defined and what the restrictions are in the jurisdiction you are involved with.&nbsp; Some fundamentals include:
  
Laws that give police, first responders, or family members, the ability to carry and administer naloxone (Narcan).
+
*501(c)3 organizations (tax-exempt nonprofits) have some restrictions on lobbying in the government. This guide explains federal laws on non-profit lobbying for policy changes.&nbsp;
  
&nbsp; Good Samaritan Laws provides immunity from criminal prosecution for drug crimes to those who use drugs and those who act in good faith and call emergency services during an overdose.<sup class="reference">[6]</sup> The Policy Surveillance Program provides an [http://lawatlas.org/query?dataset=good-samaritan-overdose-laws interactive database] of current Good Samaritan Laws in the U.S. As of July 2016, 35 states and Washington D.C. had Good Samaritan Laws in place.<sup class="reference">[7]</sup><br/> &nbsp;
+
The IRS defines direct lobbying as: "A direct lobbying communication is any attempt to influence any legislation through communication with: Any member or employee of a legislative body; or Any government official or employee (other than a member or employee of a legislative body) who may participate in the formulation of the legislation, but only if the principal purpose of the communication is to influence legislation."
  
&nbsp;
+
Direct Lobbying Communication is defined as: "Referring to specific legislation and reflects a view on such legislation."<br/> The IRS defines grassroots lobbying as: "any attempt to influence any legislation through an attempt to affect the opinions of the general public or any segment thereof."
  
== Federal Bills ==
+
*Grassroots Lobbying Communication is defined as: "Referring to specific legislation; reflecting a view on such legislation; and encouraging the recipient of the communication action with respect to such legislation."&nbsp;
  
'''S. 1455 - The Recovery Enhancement for Addiction Treatment (TREAT) Act:''' Bipartisan legislation introduced by U.S. Senators Edward Markey and Rand Paul on May 22, 2015, this bill will expand treatment for those suffering from prescription drug and heroin addiction. A companion bill was introduced in the House of Representatives by Brian Higgins, Richard Hanna, Paul Tonko, and John Katko. The legislation would expand the ability of addiction medical specialists and other trained medical professionals to provide life-saving medication-assisted therapies such as buprenorphine for patients battling opiate addiction. The bill will raise the limits on the number of patients a physician or nurse practitioner may treat from 30 to 100 in the first year and with no limit thereafter. Those providing treatment must receive additional training in addiction, use the Prescription Drug Monitoring Program (PDMP) and administer treatment in a qualified practice setting with defined oversight.<br/> <br/> '''S. 954 - The FDA Accountability Act:''' Bipartisan legislation introduced by Senator Joe Manchin on April 15, 2015. Co-sponsors include Tim Kaine, David Vitter, and Shelley Moore Capito. The bill requires the FDA to establish an advisory panel for each application submitted to the FDA for approval of an opioid drug and report to congress on any instance where approval is recommended when inconsistent with the advice of the panel. A drug approved inconsistent with the recommendations of the advisory panel shall not be introduced or delivered for introduction into interstate commerce until the report describing the approval has been submitted to Congress.<br/> <br/> '''S. 1913 - The Stopping Medication Abuse and Protecting Seniors Act:''' Bipartisan legislation introduced on July 30, 2015, by Senator Pat Toomey with co-sponsors Joe Manchin, Tim Kaine, Sherrod Brown, Rob Portman. This bill would authorize the use of patient review and restriction (PRR) programs in Medicare, which can help prevent prescription drug abuse among beneficiaries. The use of PRR programs will assign patients who are at-risk for opioid dependence to predesignated pharmacies and prescribers to better manage appropriate care and monitor prescriptions of opioid drugs for Medicare beneficiaries.<br/> <br/> '''S. 524 - 2015 Comprehensive Addiction Recovery Act:''' This legislation was re-introduced on February 15, 2015, by U.S. Senators Sheldon Whitehouse and Rob Portman and was co-sponsored by 13 additional Senators. A House of Representatives companion bill, HR 953 has also been introduced. This legislation will expand prevention and education efforts, expand access to the overdose-reversing drug Naloxone, support alternative treatment in lieu of incarceration, strengthen the Prescription Drug Monitoring Program and support expansion of the use of evidence-based treatment medications. CARA 2015 designates up to $80 million toward these efforts. This Bill became law in the summer of 2016.<br/> <br/> '''S. 799 - The Protecting our Infants Act:''' Bipartisan legislation introduced on March 19, 2015, by Senator Mitch McConnell and Casey with co-sponsors Kelley Ayotte, Rob Portman and others. Companion bill introduced in the House by Representative Clark with 72 co-sponsors. This bill requires the Agency for Healthcare Research and Quality to report on prenatal opioid abuse and neonatal abstinence syndrome (symptoms of withdrawal in a newborn). The report must include an assessment of existing research on neonatal abstinence syndrome, an evaluation of the causes, and barriers to treatment, an evaluation of treatment for pregnant women with opioids use disorders and infants with neonatal abstinence syndrome, and recommendations on preventing, identifying, and treating opioid dependency in women and neonatal abstinence syndrome. HHS is directed to develop a strategy to address gaps in research and programs and the CDC must provide technical assistance to states to improve neonatal abstinence syndrome surveillance and make surveillance data publicly available. This Bill became law on November 25th 2015.<br/> &nbsp;
+
'''The Legislative Process'''<br/> The legislative process varies between different levels of governments and in jurisdictions across the country.&nbsp; There are typically several steps in the process that provide opportunities to influence policymakers as when they are in session.&nbsp; Some states and localities have relatively short time frames to consider and pass new laws or ordinances, while other states and the federal government are in session for the many more weeks throughout the year.&nbsp; It is important to know when the actual work of policy development and consideration takes place in the legislative body where you want the change to happen.<br/> &nbsp;
  
= Examples of State Legislation =
+
'''Sponsors and Early Support'''<br/> In any legislative body, a successful policy enactment starts with one or more members of the legislative body drafting legislation that would bring about the desired change.&nbsp; Members can do this individually or as a group.&nbsp; A group of members that introduce a legislative proposal are typically referred to as sponsors or "original" sponsors of the proposal.&nbsp; Other members can then sign on in support of the bill as co-sponsors.
  
== California (Alameda County) ==
+
Effective advocacy can help build momentum for a bill during this process.&nbsp; The more sponsors and cosponsors, the better.&nbsp; It is also extremely beneficial to have early supporters from both political parties - especially at the state and federal level.&nbsp; Bipartisan support, and support among a broad base of members at the local level, can show other members that the bill is likely not controversial.&nbsp; It is also especially helpful to key leaders of the committees with jurisdiction support for the proposed legislation.
  
*Local ordinances that require drug manufacturers to establish and fund a drug disposal program.<sup class="reference">[8]</sup>
+
Advocates can provide their champions within the legislature with all of the supporting information and research to help their champions in the legislative body attract as many co-sponsors as possible and respond to questions or objections as they arise.
*California legislation has is in process for reducing treatment fraud and waste: [https://www.behavioral.net/news-item/policy/calif-bill-targets-profiteering-addiction-treatment-dialysis-industries [1]]
 
  
== Connecticut ==
+
'''Committee Process'''<br/> Typically, legislative proposals are taken up by the committee (or committees) of jurisdiction.&nbsp; Actual consideration of a proposal often takes place after one or more committee hearings on the proposal.&nbsp; This often involves hearing from witnesses in support of, and potentially in opposition to, a given proposal.&nbsp; Written testimony is also included in the public record to provide additional information to both the public and the legislators.&nbsp; The hearing process provides another opportunity for advocates to testify as a witness and/or provide information to be included in the record.&nbsp; Hearing can take place in front of the full committee or by a sub-committee which oversees the specific policy area impacted.
  
*[https://www.cga.ct.gov/2016/ACT/pa/2016PA-00043-R00HB-05053-PA.htm Statute] enacted May 2016: Seven-day limit for new opioid prescriptions for adults and all opioid prescriptions for kids. Exceptions for chronic and cancer pain, palliative care, and clinical judgement.<sup class="reference">[9]</sup>
+
After the hearing process, the bill may be taken up by the full committee for consideration.&nbsp; Although the bill can be altered by the manager of the bill at any time, consideration by the committee is the first time lawmakers have an opportunity to propose amendments to the proposal.&nbsp; These amendments are voted and adopted, or not adopted, by a majority vote.&nbsp; Following the amendment process the committee chair can call for a final vote on the legislation.&nbsp; If passed, the bill can move to the full legislative body for consideration.
  
== Illinois ==
+
Advocacy efforts can move quickly during the committee process, as unexpected challenges may surface due to an unfriendly amendment that might weaken the bill and the policy impact desired.&nbsp; It is important to work with allies to carefully track this process and respond to any negative developments.
  
*[http://www.ilga.gov/legislation/publicacts/99/PDF/099-0480.pdf Statue] enacted September 2015: Schedule II prescriptions limited to a 30-day supply (with exceptions). Allows multiple prescriptions up to a 90-day supply if the prescriber meets specified conditions.<sup class="reference">[10]</sup>
+
'''Consideration by the Full Body'''<br/> At the local level, there is a single body that approves local legislative proposals.&nbsp; This is typically a Board of Commissioners or other duly elected body.&nbsp; At the state and federal levels, there are two legislative chambers, with delegates and senators at the state level, and the House and Senate at the federal level.
  
== Kentucky ==
+
The process is usually relatively simple at the local level.&nbsp; Legislation (or ordinance) proposals are taken up at regularly scheduled meetings where a debate occurs, amendments are offered, and the proposals are voted on.&nbsp; Often, the chief executive at the local level has a vote along with the other members.
  
*Board rules required by [http://kbml.ky.gov/hb1/Documents/House-Bill-1.pdf statute] enacted September 2012: 48 hour limit on dispensing Schedule II and III controlled substances by physicians. No limit on opioid prescriptions.<sup class="reference">[11]</sup>
+
At the state and federal level, the process is more complex.&nbsp; A bill has to pass both chambers before it can be reconciled, voted on again by both bodies, and sent to the Governor or President for signature.&nbsp; While on the floor, members can again offer amendments that can be voted on individually or en bloc.&nbsp; Typically, more controversial amendments will be voted on by individual basis.&nbsp; Assuming the bill passes, it is sent to the other body for consideration.&nbsp; A similar or identical bill may be in process in that other chamber already, or it may be that no companion legislation exists.&nbsp; In the latter case the chamber that did not originate the bill will take up the version that was passed in the other chamber.
  
== Massachusetts ==
+
When a bill does pass both chambers, there are almost always differences that must be worked out.&nbsp; The committee chairs will select a reconciliation committee with a bi-partisan group of legislators from both chambers to accomplish this.&nbsp; Assuring any differences can be worked out, the bill then goes back to the floor of each chamber for a final vote.&nbsp; If passed, the bill is finally referred to the Governor or President.
  
*[https://malegislature.gov/Laws/SessionLaws/Acts/2016/Chapter52 Statute] enacted March 2016: Seven-day limit for new opioid prescriptions for adults and all opioid prescriptions for minors. Exceptions for chronic and cancer pain, palliative care, and clinical judgement.<sup class="reference">[12]</sup>
+
As with the Committee process, advocacy must continue throughout the time in which a bill is considered by the full legislative body.&nbsp; At the state and federal levels, this can be a challenge with many steps involved and a larger number of legislators to contend with - some of whom may not be supportive.&nbsp; Again, it is critical to stay in constant contact with supporters within the legislative body to keep track of potential harmful amendments and keep count of likely supporters within the full body.&nbsp; At times advocacy efforts need to be focused on a handful of legislators who have reservations or are undecided.
*[http://www.mass.gov/eohhs/docs/dph/stop-addiction/recommendations-of-the-governors-opioid-working-group.pdf Recommendations of the Governor's Opioid Working Group]
 
  
== North Carolina ==
+
'''Potential Veto and Override'''<br/> Although rare, Governors and the President may veto a bill passed by the state and federal legislators.&nbsp; If the vote on final passage were close, it is unlikely that the bill will be taken up again, as a two-thirds majority is needed to override a veto.&nbsp; If the original vote was approached the two-thirds number, there is a better chance to find the supporters needed for a successful override.
  
*[https://www.ncleg.net/gascripts/billlookup/billlookup.pl?Session=2017&BillID=H243 Statute] enacted January 1, 2017: The Strengthen Opioid Misuse Prevention (STOP) Act of 2017, or STOP Act, is intended to reduce the supply of unused, misused and diverted opioids circulating in NC, reduce “doctor shopping” and improve care by requiring prescribers to use tools and resources that help prevent inappropriate prescribing. NCMB supported passage of the STOP Act.  
+
'''Continued Funding (Budget and Appropriations)'''<br/> Even when a law or ordinance is passed and signed by the chief executive, advocacy efforts often do not end.&nbsp; This is due to the fact that legislation containing funding to implement programs is authorized (usually for a period of years), but there is still a budget and appropriations process that must be monitored over the authorization period.&nbsp; Typically, the executive branch of government produces an annual budget that reflects their policy and spending priorities.&nbsp; The budget may or may not be approved by the legislative body.&nbsp; After this point the legislative body will take up annual appropriations bills, which set spending levels for all agencies and their programs.&nbsp; These bills often work through the regular order of other legislation, but sometimes will have a different, often expedited process.&nbsp;&nbsp;
**Limits on the number of days worth of opioids that may be lawfully prescribed upon initial consultation for acute injuries (no more than a five day supply allowed) and following surgeries (no more than a seven day supply allowed). The STOP Act does NOT limit the amount of opioids that may be prescribed to a chronic pain patient;
 
**A requirement that prescribers use the NC Controlled Substances Reporting System (NCCSRS), the prescription database that records all controlled substance prescriptions dispensed in outpatient pharmacies across NC. The STOP Act requires prescribers to review the patient’s 12-month history with the NCCSRS before issuing an initial prescription for a Schedule II or Schedule III opioid, and subsequent reviews every three months thereafter, for as long as the patient continues on the drug;
 
**A requirement that PAs and NPs practicing at pain clinics consult with their supervising physicians prior to prescribing opioids. NOTE: The Board has not determined how it will define “consult”. The most important thing is that a meaningful consultation about the patient and recommended treatment occurs and is documented in the medical record; the Board may ultimately leave it up to PAs, NPs and their supervisors to determine exactly how consultations occur, consistent with its current approach towards physician supervision of PAs and NPs.<sup class="reference">[13]</sup> 
 
  
== Washington ==
+
It is important for community coalitions and advocates to understand that funding for the agencies and programs they support can change through each step of the budget and appropriations process.&nbsp; There is a need to stay vigilant and ensure full funding is achieved.&nbsp; Advocates must stay in touch with their champions in the executive branch and legislature to keep informed of any changes and be ready to advocate just as vigorously as when it is done with new initiatives in order to restore any proposed cuts in funding.&nbsp;
  
*[http://www.agencymeddirectors.wa.gov/Files/2015AMDGOpioidGuideline.pdf Guidelines] and board rules required by [http://apps.leg.wa.gov/documents/billdocs/2009-10/Pdf/Bills/Session%20Laws/House/2876-S.SL.pdf statute]. Guidelines revised June 2015, board rules implemented between July 2011 and January 2012, and statute enacted January 2010: Pain specialist consultation required prior to prescribing daily morphine equivalent doses of 120mg or greater (with exceptions).<sup class="reference">[14]</sup>
+
= Relevant Research =
*[http://leadkingcounty.org/about/ Law Enforcement Assisted Diversion]
 
  
== Rhode Island ==
+
SAFE Solutions is an ever-growing platform.&nbsp; Currently no information is readily available for this section.&nbsp; SAFE Project is dedicated to providing communities with the most relevant and innovative materials.&nbsp; We will continue to regularly monitor and make updates accordingly with community input and subject matter expert collaboration.&nbsp; Please check back soon.
  
*[http://www.health.ri.gov/news/temp/RhodeIslandsStrategicPlanOnAddictionAndOverdose.pdf Rhode Island's Strategic Plan on Addiction and Overdose]
+
= Impactful Federal, State, and Local Policies =
  
== New Jersey ==
+
'''Example of Advocacy Strategies within the Legislative Process'''<br/> The following illustrates some of the partnerships and strategies used to pass an important piece of legislation in the state of Illinois:
  
*[http://www.nj.gov/lps/ca2/pmp/ New Jersey's Prescription Monitoring Program]
+
Illinois SB2928<ref>https://ilga.gov/legislation/billstatus.asp?DocNum=2928&GAID=12&GA=98&DocTypeID=SB&LegID=79014&SessionID=85</ref> is a current law with the common name "Lake County Prescription Drug Disposal Pilot Program" which had been adopted in 2014 and is currently still functioning, losing its Pilot portion of title in 2015.&nbsp;&nbsp;It has been shown to be a model by which many organizations and local governments can partner with one another to improve outcomes in drug recovery and disposal efforts. The lead Project Coordinator Bill Gentes, has as a result, been awarded CADCA's Advocate of the Year.
*[http://www.pdmpassist.org/pdf/PPTs/DataDrivenPilots/Sources_Usage_LE_Data.pdf Regional Drug Monitoring Initiative]
 
  
<br/> [http://www.naco.org/ National Association of Counties ]<br/> &nbsp;
+
&nbsp;The following steps were used in the creation, adoption, and advocacy for this bill that allowed successful passing of it within the 98th general assembly:
  
= Recommendations from the 2017 President's Commission on Combating Drug Addiction and the Opioid Crisis =
+
*Investigation of Previous Regulation and Legislation - As is shown in the Securing Public-Private Partnerships section, it is required that one reviews current legal standings to determine if advocacy for amendment is required to allow for a more proactive approach to drug prevention to exist.&nbsp;
 +
*Partnering with Local Law Enforcement - As stated by Gentes at an interview "“circling back to law enforcement and telling them, ‘look, you guys dropped off 500 pounds and I want to tell you want that means,” makes it easy for those police departments to then get their mayors, and their village boards invested in the process."In many jurisdictions, it is regulated that only police forces may collect excess pharmaceutical products, which increases the need to partner with Local Law Enforcement even more.&nbsp;
 +
*Gaining support of Local and Community Leaders - Primarily through the method discussed in Partnering with Local Law Enforcement and through advocacy and education efforts, to have a bill passed one must show support at the local level as well as demonstrable results of local programs to garner such support. As Stated in the Route 50 Article: "Another goal for Gentes was to uncover and take advantage of the data coming out of the collection boxes. When scheduled substances are found within the boxes, the contents and amount is noted. This isn’t merely a measure to satisfy curiosity. Rather, Gentes uses the data collected as a tool to recruit new police departments to the program, and to remind participating police departments that their efforts are making a difference....'look, you guys dropped off 500 pounds and I want to tell you want that means,” makes it easy for those police departments to then get their mayors, and their village boards invested in the process."
 +
*Securing Public-Private Partnerships - Walgreens has been approached by Gentes and worked to create Prescription Drop Off and Secure Sites with partnership with local police forces and legislature. Currently expanding their drop off points to several states, there appears to be an issue with a need to review current laws regarding drug disposal. &nbsp;This has as a result increased the capacity of the project and accompanying police force in collection efforts.&nbsp;
 +
*Advocating for Adoption from State Officials - Through previous methods listed, especially community advocacy efforts, the proposal was adopted as a bill partly through the efforts of sponsor Senator Terry Link, and went on to receive unanimous support.&nbsp;
 +
*Securing Funding For A Statewide Program - In the Example of SB2928, funding would be secured in law through the Illinois EPA with the rationale that disposal of such materials would prevent drugs from tainting local water supplies, though it should be noted that labor and supplies were primarily used from local Law Enforcement Departments.&nbsp;
  
<br/> Grant Waivers to all 50 States for the IMD Exclusion<br/> [https://lac.org/wp-content/uploads/2014/07/IMD_exclusion_fact_sheet.pdf [2]]<br/> &nbsp;
+
'''Examples of Federal, State, and Local Initiatives by Topic'''<br/> States and localities vary widely on what types of laws are implemented across multiple policy areas. <ref>https://www.fda.gov/media/147152/download</ref>Below are a few examples that can provide your community coalition with some ideas on what has been passed in other states and localities.
  
*Mandate Prescriber Education
+
'''Prevention and Reduced Access to Prescription Medications'''
*Establish and fund a federal incentive to enhance access to Medication-Assisted Treatment (MAT)
 
*Require that all modes of MAT are offered at every licensed MAT facility and that those decisions are based on what is best for the patient.
 
*Partner with the National Institutes of Health (NIH) and the industry to facilitate testing and development of new MAT treatments.
 
*Provide model legislation for states to allow naloxone dispensing via standing orders, as well as requiring the prescribing of naloxone with high-risk opioid prescriptions; we must equip all law enforcement in the United States with naloxone to save lives
 
*Develop and disseminate Fentanyl detection sensors
 
*Support and fund interstate sharing of PDMP data
 
*Better align, through regulation, patient privacy laws specific to addiction with the Health Insurance Portability and Accountability Act (HIPAA) to ensure that information about SUDs be made available to medical professionals treating and prescribing medication to a patient. This could be done through the bipartisan Overdose Prevention and Patient Safety Act/Jessie’s Law
 
*Enforce the Mental Health Parity and Addiction Equity Act (MHPAEA) with a standardized parity compliance tool to ensure health plans cannot impose less favorable benefits for mental health and substance use diagnoses verses physical health diagnoses
 
  
&nbsp;
+
*New Jersey - New Jersey's Prescription Monitoring Program&nbsp;<ref>https://www.njconsumeraffairs.gov/pmp/</ref>
 +
*California (Alameda County) - Local ordinances that require drug manufacturers to establish and fund a drug disposal program.&nbsp;<ref>https://library.municode.com/ca/alameda_county/codes/code_of_ordinances?nodeId=TIT6HESA_CH6.53ALCOSADRDIOR</ref>
 +
*Connecticut - Statute <ref>https://www.cga.ct.gov/2016/ACT/pa/2016PA-00043-R00HB-05053-PA.htm</ref>enacted May 2016: Seven-day limit for new opioid prescriptions for adults and all opioid prescriptions for kids. Exceptions for chronic and cancer pain, palliative care, and clinical judgement.
 +
*Illinois - Statute enacted September 2015: Schedule II prescriptions limited to a 30-day supply (with exceptions). Allows multiple prescriptions up to a 90-day supply if the prescriber meets specified conditions.<ref>https://www.ilga.gov/legislation/publicacts/99/PDF/099-0480.pdf</ref>
  
= Federal Legislation =
+
'''Harm Reduction'''
  
*'''Affordable Care Act (2010)''' - More than 20 million people received support to get mental health and substance abuse treatment through the 2010 ACA.<sup class="reference">[15]</sup> If it is repealed and its replacement does not offer the same coverage many people will be unable to get to access treatment for addiction. The New York Time's Editorial Board states that "repealing the health care law is likely to exacerbate the crisis."<sup class="reference">[16]</sup>  
+
*AmfAR Opioid & Health indicators Database - Syringe Access Locations&nbsp;<ref>https://opioid.amfar.org/indicator/num_SSPs</ref>  
 +
*National Harm Reduction Coalition - Resources for Syringe Access and Policy<ref>https://harmreduction.org/issues/syringe-access/landscape-report/</ref>
 +
*Rhode Island - Fentanyl Testing Strip Program<ref>https://preventoverdoseri.org/fentanyl-test-strips/</ref>  
  
&nbsp;
+
'''Access to Treatment and Protecting Treatment Services'''
  
= Sample Protocol for State Law Adoption =
+
'''Federal Government - Affordable Care Act (2010)''' - More than 20 million people received support to get mental health and substance abuse treatment through the 2010 ACA.[15] If it is repealed and its replacement does not offer the same coverage many people will be unable to get to access treatment for addiction. The New York Times’ Editorial Board states that "repealing the healthcare law is likely to exacerbate the crisis."[16
  
'''[[Illinois_SB2928|Illinois]]''' '''[[Illinois_SB2928|SB2928]]''' is a current law with the common name '''"'''Lake County Prescription Drug Disposal Pilot Program" which had been adopted in 2014 and is currently still functioning, losing its Pilot portion of title in 2015. <sup class="reference">[17]</sup><sup class="reference">[18]</sup> It has been shown to be a model by which many organizations and local governments can partner with one another to improve outcomes in drug recovery and disposal efforts. <sup class="reference">[19]</sup> The lead Project Coordinator Bill Gentes has as a result been awarded CADCA's Advocate of the Year.<sup class="reference">[20]</sup> The following steps were used in the creation, adoption and advocacy for this bill that allowed successful passing of it within the 98th general assembly:
+
California legislation has a process for reducing treatment fraud and waste.&nbsp;<ref>https://www.hmpgloballearningnetwork.com/site/behavioral/news-item/policy/calif-bill-targets-profiteering-addiction-treatment-dialysis-industries</ref>
  
#Investigation of Previous Regulation and Legislation - As is shown in the Securing Public-Private Partnerships section, it is required that one review current legal standings to determine if advocacy for amendment is required to allow for a more proactive approach to drug prevention to exist.  
+
'''Criminal Justice Reform and De-criminalization.&nbsp;'''<br/> Good Samaritan Laws provide immunity from criminal prosecution for drug crimes to those who use drugs and those who act in good faith and call emergency services during an overdose.&nbsp;The Policy Surveillance Program provides an interactive database of current Good Samaritan Laws in the U.S. As of July 2016, 35 states and Washington D.C. had Good Samaritan Laws in place.<ref>https://www.ncbi.nlm.nih.gov/books/NBK542176/</ref>
#Partnering with Local Law Enforcement - As stated by Gentes at an interview "“''circling back to law enforcement and telling them, ‘look, you guys dropped off 500 pounds and I want to tell you want that means,” makes it easy for those police departments to then get their mayors, and their village boards invested in the process''."<sup class="reference">[21]</sup> In many jurisdictions, it is regulated that only police forces may collect excess pharmaceutical products, which increases the need to partner with Local Law Enforcement even more. <sup class="reference">[22]</sup>
 
#Gaining support of Local and Community Leaders - Primarily through the method discussed in Partnering with Local Law Enforcement and through advocacy and education efforts, to have a bill passed one must show support at the local level as well as demonstrable results of local programs to garner such support. As Stated in the Route 50 Article: "Another goal for Gentes was to uncover and take advantage of the data coming out of the collection boxes. When scheduled substances are found within the boxes, the contents and amount is noted. This isn’t merely a measure to satisfy curiosity. Rather, Gentes uses the data collected as a tool to recruit new police departments to the program, and to remind participating police departments that their efforts are making a difference...''.'look, you guys dropped off 500 pounds and I want to tell you want that means,” makes it easy for those police departments to then get their mayors, and their village boards invested in the process.'''"<sup class="reference">[23]</sup>
 
#Securing Public-Private Partnerships - Walgreens has been approached by Gentes and worked to create Prescription Drop Off and Secure Sites with partnership with local police forces and legislature. Currently expanding their drop off points to several states, there appears to be issue with a need to review current laws regarding drug disposal. <sup class="reference">[24]</sup> This has as a result increased the capacity of the project and accompanying police force in collection efforts.  
 
#Advocating for Adoption from State Officials - Through previous methods listed, especially community advocacy efforts, the proposal was adopted as a bill partly through the efforts of sponsor Senator Terry Link, and went on to receive unanimous support. <sup class="reference">[25]</sup>
 
#Securing Funding For A Statewide Program - In the Example of SB2928, funding would be secured in law through the Illinois EPA with the rationale that disposal of such materials would prevent drugs from tainting local water supplies, though it should be noted that labor and supplies were primarily used from local Law Enforcement Departments. <sup class="reference">[26]</sup><sup class="reference">[27]</sup>  
 
  
&nbsp;
+
*Oregon - Recent State Initiative to De-criminalize almost all narcotics:&nbsp; Measure 110, passed by a majority of statewide voters in November 2020, decriminalizes the possession of marijuana and small amounts of "harder" drugs including cocaine and methamphetamine and reduces criminal penalties for larger amounts.&nbsp; A good summary of the measure can be found here.
 +
*Washington State - Law Enforcement Assisted Diversion&nbsp;<ref>https://kingcounty.gov/depts/community-human-services/mental-health-substance-abuse/diversion-reentry-services/lead.aspx#:~:text=The%20Law%20Enforcement%20Assisted%20Diversion,behavioral%20health%20needs%20or%20poverty.</ref>
  
<div class="mw-parser-output">
+
'''Recovery Support Services'''
= Lobbying Legally =
 
<div class="_">501(c)3 organizations (tax-exempt non-profits) have some restrictions on lobbying in the government. [http://www.cadca.org/sites/default/files/resource/files/strat31.pdf This guide] explains federal laws on non-profit lobbying for policy changes.</div> <div class="_">&nbsp;[[File:LegalLobbying.PNG|LegalLobbying.PNG]]<sup class="reference">[28]</sup></div> <div class="_">&nbsp;</div>
 
== Key Lobbying Rules ==
 
  
*The IRS defines '''direct lobbying''' as: "A direct lobbying communication is any attempt to influence any legislation through communication with:Any member or employee of a legislative body; or Any government official or employee (other than a member or employee of a legislative body) who may participate in the formulation of the legislation, but only if the principal purpose of the communication is to influence legislation."
+
'''Federal SUPPORT Act: Sec. 7151'''. Building Communities of Recovery This section amends the Building Communities of Recovery (BCOR) program that was first authorized in the Comprehensive Addiction and Recovery Act (CARA) of 2016 by redefining “recovery community organization” as an organization that mobilizes resources within and outside of the recovery community, including through a peer support network. This section authorizes $5 million for each of FY 2019-2023.&nbsp;&nbsp;
**Direct Lobbying Communication is defined as: "Referring to specific legislation and reflects a view on such legislation" 
 
*The IRS defines '''grassroots lobbying''' as: "any attempt to influence any legislation through an attempt to affect the opinions of the general public or any segment thereof"
 
**Grassroots Lobbying Communication is defined as: "Referring to specific legislation; reflecting a view on such legislation; and encouraging the recipient of the communication action with respect to such legislation" 
 
  
<br/> Lobbying that falls under either the grassroots or direct lobbying definition is restricted, but not prohibited. See Tools & Resources.<br/> &nbsp;
+
'''Federal Support Act: Section 7031'''. National Recovery Housing Best Practices This section amends part D of title V of the Public Health Service Act to authorize the Sec. of HHS to identify or facilitate the development of best practices for operating recovery housing. The Secretary is directed to bring together a wide variety of stakeholders to develop best practices for Recovery Housing.
  
== Key Lobbying Groups ==
+
'''Federal and State Policy Plans to Address the Opioid Epidemic'''
  
=== FedUp! ===
+
Governments at all levels will frequently create their own set of policy goals to address a particular issue.&nbsp; This has been true for several public health issues including the current opioid epidemic.&nbsp; This process typically involves bringing numerous stakeholders together to provide education and input in coordination with government representatives who initiate the process and finalize the set of policy objectives.
  
*A grassroots coalition formed in 2012 that seeks action from the federal government to end the public health epidemic created by opioids
+
*&nbsp;Rhode Island's Strategic Plan on Addiction and Overdose<ref>https://health.ri.gov/news/temp/RhodeIslandsStrategicPlanOnAddictionAndOverdose.pdf</ref>
*FedUp accepts no money from pharmaceutical corporations and 100% of the donations they receive are directly applied to managing the costs of hosting their FedUp! rallies
+
*Massachusetts’s Recommendations of the Governor's Opioid Working Group<ref>https://www.mass.gov/lists/governors-opioid-addiction-working-group</ref>
  
<br/> To learn more go to: [http://feduprally.org/ [3]]
+
President Biden and Vice President Harris’ Year One Drug Policy Priorities<ref>https://www.whitehouse.gov/wp-content/uploads/2021/03/BidenHarris-Statement-of-Drug-Policy-Priorities-April-1.pdf?fbclid=IwAR2TBk34U_XRqlqK_pAYnUd_9f7zY3IbCQI9KxI6S5eYeRJdFzl9B09hZ84&utm_source=Faces+%26+Voices+of+Recovery&utm_campaign=1c12da631e-november-2020-advocacy-policy_COPY_01&utm_medium=email&utm_term=0_3410cda480-1c12da631e-382685157</ref> - On April 1, 2021, President Biden and Vice President Harris released their administration's Drug Policy Priorities for the upcoming year. President Biden has made clear that addressing the overdose and addiction epidemic is an urgent priority for his administration.
</div>  
 
[[Category:Pages with broken file links]]
 
  
= Tools & Resources =
+
Priorities include:
  
[[TR_-_Adopt_Key_Legislative_&_Policy_Changes_to_Address_the_Opioid_Crisis|TR - Adopt Key Legislative & Policy Changes to Address the Opioid Crisis]]
+
*Expanding access to evidence-based treatment
 +
*Advancing racial equity issues in our approach to drug policy
 +
*Enhancing evidence-based harm reduction efforts
 +
*Supporting evidence-based prevention efforts to reduce youth substance use
 +
*Reducing the supply of illicit substances
 +
*Advancing recovery-ready workplaces and expanding the addiction workforce
 +
*Expanding access to recovery support services
  
<div class="mw-parser-output">
+
&nbsp;<br/> '''Recommendations from the 2017 President's Commission on Combating Drug Addiction and the Opioid Crisis'''
= Scorecard Building =
 
  
<span style="background-color: #ffffff">Potential Objective Details</span>(Under construction)&nbsp;<br/> <span style="background-color: #ffffff">Potential Measures and Data Sources</span>(Under construction)&nbsp;<br/> <span style="background-color: #ffffff">Potential Actions and Partners</span>(Under construction)&nbsp;
+
*Establish and fund a federal incentive to enhance access to Medication-Assisted Treatment (MAT)&nbsp;  
</div>
+
*Mandate Prescriber Education&nbsp;
 +
*Require that all modes of MAT are offered at every licensed MAT facility and that those decisions are based on what is best for the patient.&nbsp;
 +
*Partner with the National Institutes of Health (NIH) and the industry to facilitate testing and development of new MAT treatments.&nbsp;  
 +
*Provide model legislation for states to allow naloxone dispensing via standing orders, as well as requiring the prescribing of naloxone with high-risk opioid prescriptions; we must equip all law enforcement in the United States with naloxone to save lives&nbsp;
 +
*Develop and disseminate Fentanyl detection sensors&nbsp;
 +
*Support and fund interstate sharing of PDMP data&nbsp;
 +
*Better align, through regulation, patient privacy laws specific to addiction with the Health Insurance Portability and Accountability Act (HIPAA) to ensure that information about SUDs be made available to medical professionals treating and prescribing medication to a patient. This could be done through the bipartisan Overdose Prevention and Patient Safety Act/Jessie’s Law&nbsp;  
 +
*Enforce the Mental Health Parity and Addiction Equity Act (MHPAEA) with a standardized parity compliance tool to ensure health plans cannot impose less favorable benefits for mental health and substance use diagnoses versus physical health diagnoses.
  
= Resources to Investigate =
+
= Available Tools and Resources =
  
[[RTI_-_Adopt_Key_Legislative_&_Policy_Changes|RTI - Adopt Key Legislative & Policy Changes]]<br/> <br/> <span style="background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px">'''<span style="color: #4d4d4d">PAGE MANAGER</span>:''' </span><span style="background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px">[insert name here]</span><br/> <span style="background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px">'''<span style="color: #4d4d4d">SUBJECT MATTER EXPERT</span>''': </span><span style="background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px">[fill out table below]</span>
+
*FedUp! - A grassroots coalition formed in 2012 that seeks action from the federal government to end the public health epidemic created by opioids.&nbsp; FedUp accepts no money from pharmaceutical corporations and 100% of the donations they receive are directly applied to managing the costs of hosting their FedUp! rallies.<ref>https://feduprally.org/</ref>  
 +
*Department of Health & Human Services Guidebook for State by State Opioid Prescribing Guidelines-<ref>https://www.azdhs.gov/documents/prevention/womens-childrens-health/injury-prevention/opioid-prevention/appendix-b-state-by-state-summary.pdf</ref>  
 +
*National Council For Behavioral Health - National Organization the advocates for mental health and substance use policies.<ref>https://www.thenationalcouncil.org/policy-agenda/</ref>
 +
*National Harm Reduction Coalition.&nbsp; Advocates for numerous harm reduction approaches.<ref>https://harmreduction.org/</ref>  
  
{| class="wiki_table"
+
&nbsp;
|-
 
| '''Reviewer'''
 
| '''Date'''
 
| '''Comments'''
 
|-
 
| &nbsp;
 
| &nbsp;
 
| &nbsp;
 
|}
 
  
= Sources =
+
= Promising Practices =
  
----
+
SAFE Solutions is an ever-growing platform.&nbsp; Currently no information is readily available for this section.&nbsp; SAFE Project is dedicated to providing communities with the most relevant and innovative materials.&nbsp; We will continue to regularly monitor and make updates accordingly with community input and subject matter expert collaboration.&nbsp; Please check back soon.
  
#[http://www.cnn.com/2016/04/28/opinions/massachusetts-opioid-treatment-prince-vox/?iid=ob_article_organicsidebar_expansion [4]]
+
= Sources =
#[http://www.modernhealthcare.com/article/20160615/NEWS/160619941?utm_source=modernhealthcare&utm_medium=email&utm_content=20160615-NEWS-160619941&utm_campaign=am [5]]
 
#[http://www.ucirvinehealth.org/health-library/content/?contentTypeID=6&contentID=712214 [6]]
 
#[http://content.healthaffairs.org/content/35/10/1876.abstract [7]]
 
#[https://www.justice.gov/file/822231/download [8]]
 
#[http://www.countyhealthrankings.org/policies/good-samaritan-drug-overdose-laws [9]]
 
#[http://lawatlas.org/query?dataset=good-samaritan-overdose-laws [10]]
 
#Hazelden Betty Ford Foundation. Heroin and Prescription Painkillers: A Toolkit for Community Action. 2016
 
#[https://www.nga.org/files/live/sites/NGA/files/pdf/2016/1607NGAOpioidRoadMap.pdf [11]]
 
#[https://www.nga.org/files/live/sites/NGA/files/pdf/2016/1607NGAOpioidRoadMap.pdf [12]]
 
#[https://www.nga.org/files/live/sites/NGA/files/pdf/2016/1607NGAOpioidRoadMap.pdf [13]]
 
#[https://www.nga.org/files/live/sites/NGA/files/pdf/2016/1607NGAOpioidRoadMap.pdf [14]]
 
##
 
##*
 
##**
 
##***
 
##****
 
##*****
 
##******
 
##*******
 
##********
 
##*********
 
##**********
 
##***********
 
##************[https://www.ncmedboard.org/resources-information/professional-resources/publications/forum-newsletter/notice/new-summary-of-ncs-new-opioids-law-the-stop-act [15]]                         
 
#[https://www.nga.org/files/live/sites/NGA/files/pdf/2016/1607NGAOpioidRoadMap.pdf [16]]
 
#[https://www.nytimes.com/2017/01/16/opinion/young-victims-of-the-opioid-epidemic.html [17]]
 
#[https://www.nytimes.com/2017/01/16/opinion/young-victims-of-the-opioid-epidemic.html [18]]
 
#[http://www.routefifty.com/2016/04/illinois-county-provides-model-get-pill-disposal-program-and-running/127855/ [19]]
 
#[http://www.ilga.gov/legislation/98/SB/09800SB2928.htm [20]]
 
#[http://police.mundelein.org/content/pill-disposal-program [21]]
 
#[http://www.cadca.org/resources/coalitions-action-how-bill-helped-pass-law [22]]
 
#[http://www.routefifty.com/2016/04/illinois-county-provides-model-get-pill-disposal-program-and-running/127855/ [23]]
 
#[http://www.routefifty.com/2016/04/illinois-county-provides-model-get-pill-disposal-program-and-running/127855/ [24]]
 
#[http://www.routefifty.com/2016/04/illinois-county-provides-model-get-pill-disposal-program-and-running/127855/ [25]]
 
#[http://police.mundelein.org/content/pill-disposal-program [26]]
 
#[http://www.ilga.gov/legislation/98/SB/09800SB2928.htm [27]]
 
#[http://police.mundelein.org/content/pill-disposal-program [28]]
 
#[http://www.routefifty.com/2016/04/illinois-county-provides-model-get-pill-disposal-program-and-running/127855/ [29]]
 
#[http://www.cadca.org/sites/default/files/resource/files/strat31.pdf [30]]
 
</div> </div> </div> </div> </div>
 
[[Category:Pages with broken file links]]
 

Latest revision as of 20:17, 30 June 2021

 

Introductory Paragraph

Educating policymakers and the general public about the legislative or policy changes necessary to create change in your community is an important step to addressing substance misuse and substance use disorder (SUD). Policies help states and local communities in several important ways:

1. By providing direct funding to communities for treatment and other services.
2. By improving access and/or affordability of care to individuals in need of assistance.
3. By removing barriers that prevent or limit the use of best practices across government agencies.

Policy change can take place at all levels of government.  This page will provide information about how policy changes typically take place, as well as some examples of federal, state, and local laws that have helped local communities.  

 

Key Information

Initial Steps for Policy Advocacy
In order to bring about policy changes through laws or ordinances, any group of citizens must be able to become a "constituency of consequence" to those with the ability to create and change policy.  This can be accomplished with a number of different advocacy approaches, as highlighted below.  A few key principles to change policy at any level of government include:

  • Have clear policy objectives.  The more specific and narrow the objective the better.  If the policy goals are too broad or general, it is easy for legislators to object on that basis.
  • Support your position.  Have research and data to support why the policy change you are seeking would be beneficial.  For example, if seeking to improve harm reduction through the creation of a needle exchange program, provide data on expected lives that will be saved, reduced medical costs, improved linkages to care, and other benefits.
  • Build a coalition.  It is important to build a coalition to increase political clout.  Think about other groups within the state or local community whose goals align with yours that would support your policy objectives and who would be willing to take action in order to achieve it.  For example, if you were advocating for a needle exchange program, you might seek support from harm reduction organizations including hospitals, community health organizations and professionals, the recovery community, families in support of recovery, the treatment community, and potentially many others.  
  • Know your opposition.  If a policy change hasn't happened, it is likely opposition exists.  It is important to learn why policymakers may be hesitant to make a certain change, including what groups oppose the policy and why.  Learning about the other side is critical to developing an effective advocacy strategy.  Overcoming opposition may require education, effective counterarguments, financial resources, and increased public awareness.
  • Identify champions.  The most successful efforts resulting in desired policy changes are led by individuals who are passionate about the issue.  Identifying and working with champions in the state or local government is a big key to success.  It is important to have people "on the inside" that can hold hearings, develop legislation, utilize input and information from stakeholders, and provide insight on the process.  Leaders within the coalition of groups seeking the policy change are also critical to identify.
  • Your voice matters.  Many times, individuals or groups with minimal advocacy experience can be intimidated by the process.  Remember that those "in power" are there because they were elected to serve.  Lawmakers across all levels of government represent the people of their states, districts, cities, towns, and so forth.  It is your constitutional right to petition the government and be heard.  Those representing the people need to hear the concerns of all those they represent.

Converting Policy Into Action
After taking the initial steps to organize, conduct both supportive and opposition research, identify champions, and reach consensus on what the policy objective(s) should be, the next step is identify and implement a set of strategies that will grow public and political support for those policies.  While approaches and specific strategies and almost innumerable, taking action involves communication and messaging intended to educate and influence.  

Grassroots Advocacy
Grassroots Advocacy generally refers to engaging the public to actively educate and lobby on behalf of a desired policy objective.  Communication occurs through letters, emails, calls to legislators, rallies, social media campaigns, letters to the editor, and other forms of messaging campaigns designed to put political pressure on policymakers to enact desired changes.  A good overview of grassroots advocacy can be found here.

Direct Lobbying
Direct lobbying refers to direct communication and meetings with policy makers, most often governors, mayors, county executives, and the legislative branch at all levels of government. This key activity provides the opportunity to meet with decision makers and their staff to discuss the desired policy goals, the benefits and support, address any likely opposition, and gauge the receptiveness of the policymakers.
Opportunities for direct lobbying often take place during the legislative session, which varies from jurisdiction to jurisdiction.  Some advocates and interest groups will organize a "lobby day" where members converge in Washington, state capitols, or with local legislative bodies to advocate for desired policy objectives.  When the legislative body is not in session, advocates can meet with their representatives at their local offices.  A good resource on the process of influencing policy can be found here.

Lobbying Rules and Restrictions
Lobbying rules vary widely between levels of government and across all states.  It is, therefore, important to know how lobbying is defined and what the restrictions are in the jurisdiction you are involved with.  Some fundamentals include:

  • 501(c)3 organizations (tax-exempt nonprofits) have some restrictions on lobbying in the government. This guide explains federal laws on non-profit lobbying for policy changes. 

The IRS defines direct lobbying as: "A direct lobbying communication is any attempt to influence any legislation through communication with: Any member or employee of a legislative body; or Any government official or employee (other than a member or employee of a legislative body) who may participate in the formulation of the legislation, but only if the principal purpose of the communication is to influence legislation."

Direct Lobbying Communication is defined as: "Referring to specific legislation and reflects a view on such legislation."
The IRS defines grassroots lobbying as: "any attempt to influence any legislation through an attempt to affect the opinions of the general public or any segment thereof."

  • Grassroots Lobbying Communication is defined as: "Referring to specific legislation; reflecting a view on such legislation; and encouraging the recipient of the communication action with respect to such legislation." 

The Legislative Process
The legislative process varies between different levels of governments and in jurisdictions across the country.  There are typically several steps in the process that provide opportunities to influence policymakers as when they are in session.  Some states and localities have relatively short time frames to consider and pass new laws or ordinances, while other states and the federal government are in session for the many more weeks throughout the year.  It is important to know when the actual work of policy development and consideration takes place in the legislative body where you want the change to happen.
 

Sponsors and Early Support
In any legislative body, a successful policy enactment starts with one or more members of the legislative body drafting legislation that would bring about the desired change.  Members can do this individually or as a group.  A group of members that introduce a legislative proposal are typically referred to as sponsors or "original" sponsors of the proposal.  Other members can then sign on in support of the bill as co-sponsors.

Effective advocacy can help build momentum for a bill during this process.  The more sponsors and cosponsors, the better.  It is also extremely beneficial to have early supporters from both political parties - especially at the state and federal level.  Bipartisan support, and support among a broad base of members at the local level, can show other members that the bill is likely not controversial.  It is also especially helpful to key leaders of the committees with jurisdiction support for the proposed legislation.

Advocates can provide their champions within the legislature with all of the supporting information and research to help their champions in the legislative body attract as many co-sponsors as possible and respond to questions or objections as they arise.

Committee Process
Typically, legislative proposals are taken up by the committee (or committees) of jurisdiction.  Actual consideration of a proposal often takes place after one or more committee hearings on the proposal.  This often involves hearing from witnesses in support of, and potentially in opposition to, a given proposal.  Written testimony is also included in the public record to provide additional information to both the public and the legislators.  The hearing process provides another opportunity for advocates to testify as a witness and/or provide information to be included in the record.  Hearing can take place in front of the full committee or by a sub-committee which oversees the specific policy area impacted.

After the hearing process, the bill may be taken up by the full committee for consideration.  Although the bill can be altered by the manager of the bill at any time, consideration by the committee is the first time lawmakers have an opportunity to propose amendments to the proposal.  These amendments are voted and adopted, or not adopted, by a majority vote.  Following the amendment process the committee chair can call for a final vote on the legislation.  If passed, the bill can move to the full legislative body for consideration.

Advocacy efforts can move quickly during the committee process, as unexpected challenges may surface due to an unfriendly amendment that might weaken the bill and the policy impact desired.  It is important to work with allies to carefully track this process and respond to any negative developments.

Consideration by the Full Body
At the local level, there is a single body that approves local legislative proposals.  This is typically a Board of Commissioners or other duly elected body.  At the state and federal levels, there are two legislative chambers, with delegates and senators at the state level, and the House and Senate at the federal level.

The process is usually relatively simple at the local level.  Legislation (or ordinance) proposals are taken up at regularly scheduled meetings where a debate occurs, amendments are offered, and the proposals are voted on.  Often, the chief executive at the local level has a vote along with the other members.

At the state and federal level, the process is more complex.  A bill has to pass both chambers before it can be reconciled, voted on again by both bodies, and sent to the Governor or President for signature.  While on the floor, members can again offer amendments that can be voted on individually or en bloc.  Typically, more controversial amendments will be voted on by individual basis.  Assuming the bill passes, it is sent to the other body for consideration.  A similar or identical bill may be in process in that other chamber already, or it may be that no companion legislation exists.  In the latter case the chamber that did not originate the bill will take up the version that was passed in the other chamber.

When a bill does pass both chambers, there are almost always differences that must be worked out.  The committee chairs will select a reconciliation committee with a bi-partisan group of legislators from both chambers to accomplish this.  Assuring any differences can be worked out, the bill then goes back to the floor of each chamber for a final vote.  If passed, the bill is finally referred to the Governor or President.

As with the Committee process, advocacy must continue throughout the time in which a bill is considered by the full legislative body.  At the state and federal levels, this can be a challenge with many steps involved and a larger number of legislators to contend with - some of whom may not be supportive.  Again, it is critical to stay in constant contact with supporters within the legislative body to keep track of potential harmful amendments and keep count of likely supporters within the full body.  At times advocacy efforts need to be focused on a handful of legislators who have reservations or are undecided.

Potential Veto and Override
Although rare, Governors and the President may veto a bill passed by the state and federal legislators.  If the vote on final passage were close, it is unlikely that the bill will be taken up again, as a two-thirds majority is needed to override a veto.  If the original vote was approached the two-thirds number, there is a better chance to find the supporters needed for a successful override.

Continued Funding (Budget and Appropriations)
Even when a law or ordinance is passed and signed by the chief executive, advocacy efforts often do not end.  This is due to the fact that legislation containing funding to implement programs is authorized (usually for a period of years), but there is still a budget and appropriations process that must be monitored over the authorization period.  Typically, the executive branch of government produces an annual budget that reflects their policy and spending priorities.  The budget may or may not be approved by the legislative body.  After this point the legislative body will take up annual appropriations bills, which set spending levels for all agencies and their programs.  These bills often work through the regular order of other legislation, but sometimes will have a different, often expedited process.  

It is important for community coalitions and advocates to understand that funding for the agencies and programs they support can change through each step of the budget and appropriations process.  There is a need to stay vigilant and ensure full funding is achieved.  Advocates must stay in touch with their champions in the executive branch and legislature to keep informed of any changes and be ready to advocate just as vigorously as when it is done with new initiatives in order to restore any proposed cuts in funding. 

Relevant Research

SAFE Solutions is an ever-growing platform.  Currently no information is readily available for this section.  SAFE Project is dedicated to providing communities with the most relevant and innovative materials.  We will continue to regularly monitor and make updates accordingly with community input and subject matter expert collaboration.  Please check back soon.

Impactful Federal, State, and Local Policies

Example of Advocacy Strategies within the Legislative Process
The following illustrates some of the partnerships and strategies used to pass an important piece of legislation in the state of Illinois:

Illinois SB2928[1] is a current law with the common name "Lake County Prescription Drug Disposal Pilot Program" which had been adopted in 2014 and is currently still functioning, losing its Pilot portion of title in 2015.  It has been shown to be a model by which many organizations and local governments can partner with one another to improve outcomes in drug recovery and disposal efforts. The lead Project Coordinator Bill Gentes, has as a result, been awarded CADCA's Advocate of the Year.

 The following steps were used in the creation, adoption, and advocacy for this bill that allowed successful passing of it within the 98th general assembly:

  • Investigation of Previous Regulation and Legislation - As is shown in the Securing Public-Private Partnerships section, it is required that one reviews current legal standings to determine if advocacy for amendment is required to allow for a more proactive approach to drug prevention to exist. 
  • Partnering with Local Law Enforcement - As stated by Gentes at an interview "“circling back to law enforcement and telling them, ‘look, you guys dropped off 500 pounds and I want to tell you want that means,” makes it easy for those police departments to then get their mayors, and their village boards invested in the process."In many jurisdictions, it is regulated that only police forces may collect excess pharmaceutical products, which increases the need to partner with Local Law Enforcement even more. 
  • Gaining support of Local and Community Leaders - Primarily through the method discussed in Partnering with Local Law Enforcement and through advocacy and education efforts, to have a bill passed one must show support at the local level as well as demonstrable results of local programs to garner such support. As Stated in the Route 50 Article: "Another goal for Gentes was to uncover and take advantage of the data coming out of the collection boxes. When scheduled substances are found within the boxes, the contents and amount is noted. This isn’t merely a measure to satisfy curiosity. Rather, Gentes uses the data collected as a tool to recruit new police departments to the program, and to remind participating police departments that their efforts are making a difference....'look, you guys dropped off 500 pounds and I want to tell you want that means,” makes it easy for those police departments to then get their mayors, and their village boards invested in the process."
  • Securing Public-Private Partnerships - Walgreens has been approached by Gentes and worked to create Prescription Drop Off and Secure Sites with partnership with local police forces and legislature. Currently expanding their drop off points to several states, there appears to be an issue with a need to review current laws regarding drug disposal.  This has as a result increased the capacity of the project and accompanying police force in collection efforts. 
  • Advocating for Adoption from State Officials - Through previous methods listed, especially community advocacy efforts, the proposal was adopted as a bill partly through the efforts of sponsor Senator Terry Link, and went on to receive unanimous support. 
  • Securing Funding For A Statewide Program - In the Example of SB2928, funding would be secured in law through the Illinois EPA with the rationale that disposal of such materials would prevent drugs from tainting local water supplies, though it should be noted that labor and supplies were primarily used from local Law Enforcement Departments. 

Examples of Federal, State, and Local Initiatives by Topic
States and localities vary widely on what types of laws are implemented across multiple policy areas. [2]Below are a few examples that can provide your community coalition with some ideas on what has been passed in other states and localities.

Prevention and Reduced Access to Prescription Medications

  • New Jersey - New Jersey's Prescription Monitoring Program [3]
  • California (Alameda County) - Local ordinances that require drug manufacturers to establish and fund a drug disposal program. [4]
  • Connecticut - Statute [5]enacted May 2016: Seven-day limit for new opioid prescriptions for adults and all opioid prescriptions for kids. Exceptions for chronic and cancer pain, palliative care, and clinical judgement.
  • Illinois - Statute enacted September 2015: Schedule II prescriptions limited to a 30-day supply (with exceptions). Allows multiple prescriptions up to a 90-day supply if the prescriber meets specified conditions.[6]

Harm Reduction

  • AmfAR Opioid & Health indicators Database - Syringe Access Locations [7]
  • National Harm Reduction Coalition - Resources for Syringe Access and Policy[8]
  • Rhode Island - Fentanyl Testing Strip Program[9]

Access to Treatment and Protecting Treatment Services

Federal Government - Affordable Care Act (2010) - More than 20 million people received support to get mental health and substance abuse treatment through the 2010 ACA.[15] If it is repealed and its replacement does not offer the same coverage many people will be unable to get to access treatment for addiction. The New York Times’ Editorial Board states that "repealing the healthcare law is likely to exacerbate the crisis."[16

California legislation has a process for reducing treatment fraud and waste. [10]

Criminal Justice Reform and De-criminalization. 
Good Samaritan Laws provide immunity from criminal prosecution for drug crimes to those who use drugs and those who act in good faith and call emergency services during an overdose. The Policy Surveillance Program provides an interactive database of current Good Samaritan Laws in the U.S. As of July 2016, 35 states and Washington D.C. had Good Samaritan Laws in place.[11]

  • Oregon - Recent State Initiative to De-criminalize almost all narcotics:  Measure 110, passed by a majority of statewide voters in November 2020, decriminalizes the possession of marijuana and small amounts of "harder" drugs including cocaine and methamphetamine and reduces criminal penalties for larger amounts.  A good summary of the measure can be found here.
  • Washington State - Law Enforcement Assisted Diversion [12]

Recovery Support Services

Federal SUPPORT Act: Sec. 7151. Building Communities of Recovery This section amends the Building Communities of Recovery (BCOR) program that was first authorized in the Comprehensive Addiction and Recovery Act (CARA) of 2016 by redefining “recovery community organization” as an organization that mobilizes resources within and outside of the recovery community, including through a peer support network. This section authorizes $5 million for each of FY 2019-2023.  

Federal Support Act: Section 7031. National Recovery Housing Best Practices This section amends part D of title V of the Public Health Service Act to authorize the Sec. of HHS to identify or facilitate the development of best practices for operating recovery housing. The Secretary is directed to bring together a wide variety of stakeholders to develop best practices for Recovery Housing.

Federal and State Policy Plans to Address the Opioid Epidemic

Governments at all levels will frequently create their own set of policy goals to address a particular issue.  This has been true for several public health issues including the current opioid epidemic.  This process typically involves bringing numerous stakeholders together to provide education and input in coordination with government representatives who initiate the process and finalize the set of policy objectives.

  •  Rhode Island's Strategic Plan on Addiction and Overdose[13]
  • Massachusetts’s Recommendations of the Governor's Opioid Working Group[14]

President Biden and Vice President Harris’ Year One Drug Policy Priorities[15] - On April 1, 2021, President Biden and Vice President Harris released their administration's Drug Policy Priorities for the upcoming year. President Biden has made clear that addressing the overdose and addiction epidemic is an urgent priority for his administration.

Priorities include:

  • Expanding access to evidence-based treatment
  • Advancing racial equity issues in our approach to drug policy
  • Enhancing evidence-based harm reduction efforts
  • Supporting evidence-based prevention efforts to reduce youth substance use
  • Reducing the supply of illicit substances
  • Advancing recovery-ready workplaces and expanding the addiction workforce
  • Expanding access to recovery support services

 
Recommendations from the 2017 President's Commission on Combating Drug Addiction and the Opioid Crisis

  • Establish and fund a federal incentive to enhance access to Medication-Assisted Treatment (MAT) 
  • Mandate Prescriber Education 
  • Require that all modes of MAT are offered at every licensed MAT facility and that those decisions are based on what is best for the patient. 
  • Partner with the National Institutes of Health (NIH) and the industry to facilitate testing and development of new MAT treatments. 
  • Provide model legislation for states to allow naloxone dispensing via standing orders, as well as requiring the prescribing of naloxone with high-risk opioid prescriptions; we must equip all law enforcement in the United States with naloxone to save lives 
  • Develop and disseminate Fentanyl detection sensors 
  • Support and fund interstate sharing of PDMP data 
  • Better align, through regulation, patient privacy laws specific to addiction with the Health Insurance Portability and Accountability Act (HIPAA) to ensure that information about SUDs be made available to medical professionals treating and prescribing medication to a patient. This could be done through the bipartisan Overdose Prevention and Patient Safety Act/Jessie’s Law 
  • Enforce the Mental Health Parity and Addiction Equity Act (MHPAEA) with a standardized parity compliance tool to ensure health plans cannot impose less favorable benefits for mental health and substance use diagnoses versus physical health diagnoses.

Available Tools and Resources

  • FedUp! - A grassroots coalition formed in 2012 that seeks action from the federal government to end the public health epidemic created by opioids.  FedUp accepts no money from pharmaceutical corporations and 100% of the donations they receive are directly applied to managing the costs of hosting their FedUp! rallies.[16]
  • Department of Health & Human Services Guidebook for State by State Opioid Prescribing Guidelines-[17]
  • National Council For Behavioral Health - National Organization the advocates for mental health and substance use policies.[18]
  • National Harm Reduction Coalition.  Advocates for numerous harm reduction approaches.[19]

 

Promising Practices

SAFE Solutions is an ever-growing platform.  Currently no information is readily available for this section.  SAFE Project is dedicated to providing communities with the most relevant and innovative materials.  We will continue to regularly monitor and make updates accordingly with community input and subject matter expert collaboration.  Please check back soon.

Sources

  1. ^ https://ilga.gov/legislation/billstatus.asp?DocNum=2928&GAID=12&GA=98&DocTypeID=SB&LegID=79014&SessionID=85
  2. ^ https://www.fda.gov/media/147152/download
  3. ^ https://www.njconsumeraffairs.gov/pmp/
  4. ^ https://library.municode.com/ca/alameda_county/codes/code_of_ordinances?nodeId=TIT6HESA_CH6.53ALCOSADRDIOR
  5. ^ https://www.cga.ct.gov/2016/ACT/pa/2016PA-00043-R00HB-05053-PA.htm
  6. ^ https://www.ilga.gov/legislation/publicacts/99/PDF/099-0480.pdf
  7. ^ https://opioid.amfar.org/indicator/num_SSPs
  8. ^ https://harmreduction.org/issues/syringe-access/landscape-report/
  9. ^ https://preventoverdoseri.org/fentanyl-test-strips/
  10. ^ https://www.hmpgloballearningnetwork.com/site/behavioral/news-item/policy/calif-bill-targets-profiteering-addiction-treatment-dialysis-industries
  11. ^ https://www.ncbi.nlm.nih.gov/books/NBK542176/
  12. ^ https://kingcounty.gov/depts/community-human-services/mental-health-substance-abuse/diversion-reentry-services/lead.aspx#:~:text=The%20Law%20Enforcement%20Assisted%20Diversion,behavioral%20health%20needs%20or%20poverty.
  13. ^ https://health.ri.gov/news/temp/RhodeIslandsStrategicPlanOnAddictionAndOverdose.pdf
  14. ^ https://www.mass.gov/lists/governors-opioid-addiction-working-group
  15. ^ https://www.whitehouse.gov/wp-content/uploads/2021/03/BidenHarris-Statement-of-Drug-Policy-Priorities-April-1.pdf?fbclid=IwAR2TBk34U_XRqlqK_pAYnUd_9f7zY3IbCQI9KxI6S5eYeRJdFzl9B09hZ84&utm_source=Faces+%26+Voices+of+Recovery&utm_campaign=1c12da631e-november-2020-advocacy-policy_COPY_01&utm_medium=email&utm_term=0_3410cda480-1c12da631e-382685157
  16. ^ https://feduprally.org/
  17. ^ https://www.azdhs.gov/documents/prevention/womens-childrens-health/injury-prevention/opioid-prevention/appendix-b-state-by-state-summary.pdf
  18. ^ https://www.thenationalcouncil.org/policy-agenda/
  19. ^ https://harmreduction.org/